A circadian rhythm is any biological process that displays an endogenous, entrainable oscillation of about 24 hours. These 24-hour rhythms are driven by a circadian clock, and they have been widely observed in plants, animals, fungi, and cyanobacteria. Circadian rhythm sleep treatment follows two pathways, which include utilizing drug therapy or light therapy that involves the usage of certain devices.
This report contains market size and forecasts of Circadian Rhythm Sleep Treatment in Global, including the following market information:
Global Circadian Rhythm Sleep Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Circadian Rhythm Sleep Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Drug Therapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Circadian Rhythm Sleep Treatment include Natus Medical, Compumedics, Teva Pharmaceuticals, Takeda Pharmaceutical, Koninklijke Philips, Mylan, Fitbit, Garmin and Lucimed (Luminette), etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Circadian Rhythm Sleep Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Circadian Rhythm Sleep Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Circadian Rhythm Sleep Treatment Market Segment Percentages, by Type, 2021 (%)
Drug Therapy
Light Therapy
Global Circadian Rhythm Sleep Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Circadian Rhythm Sleep Treatment Market Segment Percentages, by Application, 2021 (%)
Delayed Sleep Phase Syndrome (DSPS)
Advanced Sleep Phase Syndrome (ASPS)
Irregular Sleep-Wake Disorder (ISWD)
Others
Global Circadian Rhythm Sleep Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Circadian Rhythm Sleep Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Circadian Rhythm Sleep Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Circadian Rhythm Sleep Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Natus Medical
Compumedics
Teva Pharmaceuticals
Takeda Pharmaceutical
Koninklijke Philips
Mylan
Fitbit
Garmin
Lucimed (Luminette)
Compass Health Brands (Carex Health)
Lanaform